Clinical Study

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 9

Trend of serum CgA values comparing baseline and end-treatment levels are tabulated on the basis of patients’ functional response in the 23/59 cases in which discordant results between CgA trend and 68Ga-peptide PET/CT results were observed.

Functional responseCgA values
IncreasedStable$Decreased

PR (9/23)7*2
SD (10/23) 6 4§
PD (4/23)4

$ V a r i a t i o n   ≤ 10%;  *mean variation = 271  ±  220 (range 15–682); m e a n variation = 104  ±  119 (range 3–305); §mean variation = 669 ± 554 (range 41–1343).